Filing Record and Reported Relationship

The relevant EDGAR record is accession 0000912282-26-000811, observed in the registry on 2026-07-26. In that filing, Charles Ryan is listed with the designation Executive Officer in connection with Quince Therapeutics, Inc.. These labels report the relationship asserted in the filing; they should not be expanded into a more specific operating, ownership, or investment role without separate evidence.